Revance therapeutics class action reminder

Securities litigation partner james (josh) wilson encourages investors who suffered losses exceeding $100,000 in revance therapeutics to contact him directly to discuss their optionsnew york, new york--(newsfile corp. - january 23, 2022) - faruqi & faruqi, llp, a leading national securities law firm, is investigating potential claims against revance therapeutics, inc. ("revance therapeutics" or the "company") (nasdaq: rvnc) and reminds investors of the february 8, 2022 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the company. if you suffered losses exceeding $100,000 investing in revance therapeutics stock...
RVNC Ratings Summary
RVNC Quant Ranking